Jan. 15, 2025 — Researchers have designed process that uses ultrasound to modify the behavior of cancer-fighting T cells by increasing their cell permeability. They targeted freshly isolated ...

Cutaneous disease is a frequent cause of morbidity in the homeless. Several skin conditions, both infectious and noninfectious, have been described in the homeless population including trauma ...

High-frequency ultrasound (HFUS) is emerging as a valuable ... assess the morphological characteristics and thickness of cutaneous basal cell carcinoma (BCC), providing critical information ...

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.

The combination produced 100 breeds of microbubbles for ultrasound exams, from which the most efficient contrast agent was selected and tested on a live rat by visualizing its beating heart.

No statistically significant differences were observed between the ultrasound findings and age, sex, height, weight, or BMI.

New York, NY 10021, USA; bykerkv{at}hss.edu Objective To determine the comparative effectiveness of oral versus subcutaneous methotrexate (MTX) as initial therapy for patients with early rheumatoid ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

But after a couple of years of work, xMEMS has arrived at the next generation — ultrasound through a solid-state speaker. This tiny, 1mm-thin speaker is called Cypress, and after listening to it ...

See a doctor who has experience with it. You’ll find dermatologists who have experience with cutaneous T-cell lymphoma at Find a Dermatologist. Click on "Filters". Select "Any condition" and choose ...

The subcutaneous formulation of Opdivo provides a convenient alternative to intravenous administration for patients with solid tumors, maintaining efficacy and safety. The CHECKMATE-67T trial ...